Drug Trial Radar · NCT00066170
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Last checked: Nov 19, 2026Latest source record: Dec 29, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
231
Actual
Start
Apr 2003
Primary completion
Jul 2004
Study completion Nov 2004
Sponsor
- Lead sponsor
- Jazz PharmaceuticalsJazz Pharmaceuticals (JAZZ)
- Sponsor type
- Industry
- First posted
- Aug 6, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will be conducted as a randomized, double blind, double-dummy, placebo-controlled, parallel-group trial in patients diagnosed with narcolepsy. Volunteers for this trial will be required to make 5 visits over up to 14 weeks to a participating expert physician practitioner for various sleep and narcolepsy evaluations and diaries will also be collected. Participants will take assigned medications during the course of the trial. Subjects will have a 25% probability of receiving placebo for both drugs (modafinil and Xyrem). All subject volunteers must meet criteria for narcolepsy and have evidence of daytime sleepiness. Patients will not incur any personal medical expenses due to participation in this trial. The sponsor is covering all visit costs not covered by insurance and there are some funds for patient expenses such as travel.
Conditions
- Narcolepsy
Interventions
XyremDrug
Xyrem oral solution at 6 g/day for 4 weeks and 9 g/day for another 4 weeks.
Xyrem PlaceboDrug
Xyrem Placebo oral solution 12 ml per day for 4 weeks and 18 ml per day for another 4 weeks.
Modafinil at established doseDrug
Modafinil oral capsules at 200 to 600 mg per day for 8 weeks.
Modafinil (Placebo)Drug
Modafinil Placebo oral capsules 1 to 3 capsules per day for 8 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Daytime Sleep Latency as Measured by the Maintenance of Wakefulness Test (MWT)Time frame: Baseline to Week 8
Locations
40 sites in 4 countries. Site status is shown where the registry gives one.
Pulmonary Associates, PA
Phoenix, Arizona
St. Jude Medical Center -- Sleep Disorders Institute
Fullerton, California
Pacific Sleep Medicine Services, Inc.
Los Angeles, California
Neuro-Therapeutics, Inc.
Pasadena, California
Pacific Sleep Medicine Services, Inc.
San Diego, California
Stanford Sleep Disorders Clinic
Stanford, California
Clinical Research Group of St. Petersburg, Inc.
St. Petersburg, Florida
Peoria Pulmonary Associates, Ltd
Peoria, Illinois
The Center for Sleep and Wake Disorders/Midwest Neurology
Danville, Indiana
Graves Gilbert Clinic
Bowling Green, Kentucky
Community Research & Sleep Management Institute
Crestview Hills, Kentucky
Chest Medicine Associates DBA -- Sleep Medicine Specialists
Louisville, Kentucky
The Center for Sleep & Wake Disorders
Chevy Chase, Maryland
Sleep Disorders Center -- Union Hospital of Cecil County
Elkton, Maryland
Sleep Medicine Associates of Maryland
Towson, Maryland
Henry Ford Hospital
Detroit, Michigan
Washington University Sleep Center
St Louis, Missouri
New Jersey Neuroscience Institute at JFK Medical Center
Edison, New Jersey
Sleep Disorders Center of Rochester
Rochester, New York
Strong Sleep Disorders Center
Rochester, New York
Raleigh Neurology Associates
Raleigh, North Carolina
ALL-TRIALS Clinical Research, LLC -- Summit Sleep Disorder
Winston-Salem, North Carolina
Cincinnati Clinic & Sleep Management Institute
Cincinnati, Ohio
Community Research Management Associates,Inc.
Cincinnati, Ohio
CSC Research -- Grove City Sleep Diagnostic Center
Grove City, Ohio
Lehigh Valley Hospital Sleep Disorders Center
Allentown, Pennsylvania
Capital Region Sleep Disorder Center
Carlisle, Pennsylvania
Center for Sleep Medicine
Lafayette Hill, Pennsylvania
Lowcountry Lung and Critical Care, PA
Charleston, South Carolina
SleepMed of South Carolina
Columbia, South Carolina
SDHRF Clinical Research Center
Sioux Falls, South Dakota
Sioux Valley Clinic -- Pulmonary
Sioux Falls, South Dakota
Sleep Disorders Center
Sioux Falls, South Dakota
Bhupesh Dihenia, MD
Lubbock, Texas
SLEEP WALKER -- Sleep Disorders Center & Neurodiagnostics--Lung Diagnostics, Ltd.
San Antonio, Texas
Vermont Medical Sleep Disorders Center, Inc.
Essex Junction, Vermont
Hopital Pitie Salpetriere -- Federation des Pathologies du sommeil
Paris, Cedex 13, France
Centre du sommeil -- Hopital Gui de Chauliac
Montpellier, Cedex 5, France
Psychiatrische Universitatsklinik
Regensburg, Germany
Neurologische Poliklinik -- Universitats Spital Zurich
Zurich, Switzerland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.